Strides Pharma develops Favipiravir antiviral tablets; drug shows positive outcome in COVID-19 treatment

Strides Pharma Science Ltd on Wednesday said it has developed and commercialised Favipiravir antiviral tablets and stressed that the drug has demonstrated positive outcomes in COVID-19 treatment globally.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2VMFNlB
via IFTTT